论文部分内容阅读
目的观察维拉帕米治疗心律失常的疗效及安全性。方法选取医院收治的室上性心律失常患者120例为研究对象,随机分为观察组和对照组,每组60例。对照组采用普罗帕酮治疗,观察组采用维拉帕米治疗,观察2组患者的临床疗效及不良反应发生情况。结果观察组总有效率为95.0%,高于对照组的84.9%(P<0.05)。观察组不良反应发生率为1.7%,低于对照组的8.3%(P<0.05)。结论对心律失常患者的治疗,应掌握好个体化用药原则,维拉帕米可治疗老年快速室上性心律失常。
Objective To observe the efficacy and safety of verapamil in the treatment of arrhythmia. Methods A total of 120 patients with supraventricular arrhythmia admitted to the hospital were selected as study subjects and randomly divided into observation group and control group with 60 cases in each group. The control group was treated with propafenone. The observation group was treated with verapamil. The clinical efficacy and adverse reactions of the two groups were observed. Results The total effective rate in the observation group was 95.0%, higher than that in the control group (84.9%, P <0.05). The incidence of adverse reactions in the observation group was 1.7%, which was lower than 8.3% in the control group (P <0.05). Conclusion For the treatment of patients with arrhythmia, the principle of individualized medication should be mastered. Verapamil may be used to treat the elderly patients with rapid supraventricular arrhythmias.